Estrella Immunopharma names Cynthia Pussinen CEO and board chair
Cheng Liu moves from CEO to Chief Scientific Officer while remaining President and a director, the company said in an October 29, 2026 filing.
SEC filing
Latest
1 story
Sign inSign in1 story
Cheng Liu moves from CEO to Chief Scientific Officer while remaining President and a director, the company said in an October 29, 2026 filing.
SEC filing